Position 5-7: Finalization

Oropharynx

Select the specific approach and device combination to identify the exact billable procedure code.

Approach 9

High Dose Rate (HDR)

Device 7

D91F97Z Brachytherapy Oropharynx to None with Cesium 137 (Cs-137), High Dose Rate (HDR) Approach

Device 8

D91F98Z Brachytherapy Oropharynx to None with Iridium 192 (Ir-192), High Dose Rate (HDR) Approach

Device 9

D91F99Z Brachytherapy Oropharynx to None with Iodine 125 (I-125), High Dose Rate (HDR) Approach

Device B

D91F9BZ Brachytherapy Oropharynx to None with Palladium 103 (Pd-103), High Dose Rate (HDR) Approach

Device C

D91F9CZ Brachytherapy Oropharynx to None with Californium 252 (Cf-252), High Dose Rate (HDR) Approach

Device Y

D91F9YZ Brachytherapy Oropharynx to None with Other Isotope, High Dose Rate (HDR) Approach
Approach B

Low Dose Rate (LDR)

Device 6

D91FB6Z Brachytherapy Oropharynx to None with Cesium 131 (Cs-131), Low Dose Rate (LDR) Approach

Device 7

D91FB7Z Brachytherapy Oropharynx to None with Cesium 137 (Cs-137), Low Dose Rate (LDR) Approach

Device 8

D91FB8Z Brachytherapy Oropharynx to None with Iridium 192 (Ir-192), Low Dose Rate (LDR) Approach

Device 9

D91FB9Z Brachytherapy Oropharynx to None with Iodine 125 (I-125), Low Dose Rate (LDR) Approach

Device B

D91FBB1 Brachytherapy Oropharynx to Unidirectional Source with Palladium 103 (Pd-103), Low Dose Rate (LDR) Approach
D91FBBZ Brachytherapy Oropharynx to None with Palladium 103 (Pd-103), Low Dose Rate (LDR) Approach

Device C

D91FBCZ Brachytherapy Oropharynx to None with Californium 252 (Cf-252), Low Dose Rate (LDR) Approach

Device Y

D91FBYZ Brachytherapy Oropharynx to None with Other Isotope, Low Dose Rate (LDR) Approach